K2M announced that members of its management team will present at a number of investor conferences in June.
Here are five key updates from K2M:
1. Eric Major, president and CEO, and Greg Cole, CFO of the company will present at William Blair 34th Annual Growth Stock Conference in Chicago. Also, Mr. Cole will present at the 2014 Wells Fargo Healthcare Conference in Boston.
2. K2M is a global medical device company focused on designing, developing and commercializing complex spine and minimally invasive spine technologies and techniques.
"What we have to do is provide surgeons with forward thinking innovation. We have to be responsive to their needs," said Mr. Major in his recent appearance on the on the NASDAQ CEO Signature Series. "Today our primary competitors in that space are Medtornic and J&J, and they have great products but we believe to win in that space we have to continue to innovate and for our investors deliver that top line growth and move toward profitability."
3. The company filed for an initial public offering in March. It planned on raising between $141 million and $159 million and had priced its IPO at $15 per share. It received net proceeds of approximately $120 million from the offering, after deducting underwriting discounts and estimated offering expenses. Piper Jaffray, Barclays and Wells Fargo Securities were the joint underwriters on the deal,
4. The company is growing rapidly and in January 2014, it received U.S. Food and Drug Administration 510(k) clearance for its CAYMAN Minimally Invasive, the newest of the CAYMAN plate systems. The CAYMAN Minimally Invasive is a single-level lateral plate with a low profile and four-screw construct. Other products in the CAYMAN line include the anterior, buttress and lateral plates.
5. The company has brought 11 devices to market since 2011. "The regulatory environment is always changing but what we have to do as an entrepreneurial-focused organization is continue to find ways to innovate," said Mr. Major in the NASDAQ CEO Signature Series.
More Articles on Devices:
5 Key Results: LDR's Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE's Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018